FindTrial
Sign In

Identification of SNPs for predicting nasopharyngeal carcinoma response to radiotherapy

Identification of SNPs for predicting nasopharyngeal carcinoma response to radiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RON-15005914
Enrollment
Unknown
Registered
2015-01-29
Start date
2015-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal carcinoma

Interventions

1:nil

Sponsors

Institute of Clinical Pharmacology, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. pathologically confirmed NPC; 2. Karnofsky score more than 70; 3. received RT, or RT/CRT regimen; 4. with available blood sample and biopsy specimens; 5. follow-up regularly.

Exclusion criteria

Exclusion criteria: 1. have radiotherapy history, chemotherapy history,surgery treatment history; 2. have previous malignant disease or a second primary tumor; 3. have metastasis or recurrence.

Design outcomes

Primary

MeasureTime frame
genotype;survival time;recurrence;metastasis;mucositis;dermatitis;—

Countries

China

Contacts

Public ContactWei Zhang
yjsd2003@163.com+86 13973168774

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026